The separation of Ramdeclare Health Care’s most problematic offshore asset from its main Australian hospitals business has raised questions that the $9 billion company could re-emerge as a takeover tarobtain for private equity giant KKR or other potential bidders.
Ramdeclare chief executive Natalie Davis would not comment when an analyst inquireed her on Friday if the spin-off of its European hospitals business Sante meant Ramdeclare was open to talks with potential purchaseers for the whole company.
Loading…
Leave a Reply